PharmaVoice

JULY 26, 2022

A look at Congress’ push to pass drug pricing reform and why the latest attempt could actually succeed.

264

264

Pharmacy Times

JULY 26, 2022

The bill allows pharmacists to dispense and administer drugs, order laboratory tests, and consult patients on HIV pre- and post-exposure drugs.

149

149

pharmaphorum

JULY 26, 2022

Newly diagnosed cancer patients across the UK will get free access to digital mental health therapies, thanks to a new partnership between Macmillan Cancer Support and Big Health. The alliance, billed as the first of its kind in the UK, means that cancer patients will be able to use Big Health apps like Sleepio and Daylight, which aim to treat insomnia and anxiety using cognitive behavioural therapy (CBT) techniques.

134

134

Pharmacy Times

JULY 26, 2022

This month, we tackled how to find and utilize a mentor both as a pharmacy student and after graduation.

123

123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

JULY 26, 2022

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. The three major markets (3MM: the US, Germany and the UK) will increase in market size from $128.35m last year to $188.35m in 2031, at a compound annual growth rate (CAGR) of 3.9%.

Compounding 122

Compounding Labelling 122

Pharmacy Times

JULY 26, 2022

A variety of cannabidiol (CBD) products incorrectly listed their CBD and tetrahydrocannabinol content, in addition to making therapeutic and cosmetic claims without FDA approval.

Labelling 123

Labelling FDA 123

Pharmacy Times

JULY 26, 2022

COVID-19 vaccination averted infection in 10% of NHS health care workers and reduced absence from work by nearly 70%.

Vaccines 115

Vaccines 115

Pharmaceutical Technology

JULY 26, 2022

The US Food and Drug Administration (FDA) has accepted the biologics licence application (BLA) of Novartis subsidiary Sandoz for natalizumab, a proposed first-ever multiple sclerosis (MS) biosimilar to reference medicine Tysabri. Natalizumab is developed by Sandoz’s collaboration partner Polpharma Biologics. The biosimilar has an intravenous (IV) dosing form, dosing route, regimen and presentation in line with the reference medicine.

FDA 64

FDA Packaging 64

Pharmacy Times

JULY 26, 2022

Fewer than half of eligible veterans enrolled in the Veterans Health Administration have received their COVID-19 booster.

111

111

Pharmaceutical Technology

JULY 26, 2022

Ginkgo Bioworks has signed a definitive agreement for the acquisition of biotechnology company Zymergen in an all-stock deal worth nearly $300m. According to the agreement, 5.25% of the pro forma merged business will be owned by the stockholders of Zymergen following the acquisition. The deal to combine two complementary companies with identical visions is anticipated to expedite the development of the innovative horizontal synthetic biology platform of Ginkgo.

64

64

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 26, 2022

When pharmacists are involved in the care process, they can address common barriers to medication use, such as polypharmacy, ineffective medication, high costs, health and lifestyle considerations, and social needs.

94

94

Pharmaceutical Technology

JULY 26, 2022

North America was the fastest growing region for fintech hiring among pharmaceutical industry companies in the three months ending May. The number of roles in North America made up 18.2% of total fintech jobs - up from 0% in the same quarter last year. That was followed by Europe, which saw a 2.3 year-on-year percentage point change in fintech roles.

59

59

Pharmacy Times

JULY 26, 2022

AfterBurn gel offers relief for sunburn, scalds, and other types of burns.

65

65

Pharmaceutical Technology

JULY 26, 2022

NewAmsterdam Pharma has signed a definitive business combination agreement with special purpose acquisition company (SPAC) Frazier Lifesciences Acquisition (FLAC). The SPAC is sponsored by a Frazier Healthcare Partners affiliate. The deal will make NewAmsterdam Pharma a publicly listed company focusing on oral treatments for cardiometabolic diseases.

59

59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 26, 2022

Tapinarof (Vtama) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults.

65

65

Fuld

JULY 26, 2022

A time of reckoning. Following a decade-long bull run, exuberance in the public markets is in its final stages. This is a consequence of influential paradigm shifts – not just in financial markets, but in the economic outlook, geopolitical changes, and the rising interest rate regime – all of which are putting downward pressure on assets of all classes.

Immunization 59

Immunization 59

Pharmacy Times

JULY 26, 2022

When we talk about access, that is a pharmacist.

Independent Pharmacies 65

Independent Pharmacies 65

Pharma Times

JULY 26, 2022

Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 26, 2022

This month's featured products include prenatal supplements, an intensive hydrating serum, and more.

65

65

Pharma Times

JULY 26, 2022

Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation

52

52

Pharmacy Times

JULY 26, 2022

Key opinion leaders evaluate treatment options for MCL while emphasizing payer considerations.

65

65

Board Vitals - Pharmacist

JULY 26, 2022

Your Cardiology MOC exam is coming up, have you started preparing? This certification is known to be one of the harder ones, with a pass rate of 88% in 2021 , so don’t procrastinate studying. It may take some time to get back into the swing of studying but here are some quick tips to help you out: Start studying early, make a study schedule, get plenty of sleep, and use practice tests to quiz yourself.

52

52

Pharmacy Times

JULY 26, 2022

Drs Haumschild, Jain, and Wang evaluate MCL therapies under investigation and the impact on the future of MCL treatment.

65

65

Viseven

JULY 26, 2022

Apart from high-quality care, personalization, and transparency, patients are eager to have more control over their time and day-to-day health activities with easy access to accurate medical information. A mobile app is a perfect tool to satisfy all these needs. mHealth apps don’t aim to replace doctors and medical devices but to revolutionize the healthcare system by improving healthcare delivery.

Health and Personal Care Stores 52

Health and Personal Care Stores Dosage Communication Medical Records 52

Pharmacy Times

JULY 26, 2022

The experts provide their closing thoughts and discuss unmet needs in the treatment of patients with MCL.

65

65

pharmaphorum

JULY 26, 2022

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide. Preventative vaccines have already proven to be highly effective against certain cancer types.

Vaccines 52

Vaccines Immunization 52

Pharmacy Times

JULY 26, 2022

How would you handle these patient questions?

65

65

Outsourcing Pharma

JULY 26, 2022

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Bidenâs call to improve screening and treatment options.

52

52

PharmExec

JULY 26, 2022

With debate swirling around products cleared through this pathway, reforms and tighter oversight likely.

FDA 52

FDA 52

Pharmaceutical Technology

JULY 26, 2022

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. Scientists are not just studying specific mutations associated with medical conditions, but also establishing frameworks to understand the role of chromosomal instability and copy number changes in driving those disorders.

52

52

pharmaphorum

JULY 26, 2022

The 5th Annual Targeted Protein Degradation Summit returns to Boston as the most comprehensive, definitive event of the year, uniting 700+ large pharma, innovative biotech and world-renowned academics to discuss the full breadth of protein degrader drug development. With 85+ world-class speakers delivering their latest findings, join them for 4 days of cutting-edge science, ample networking opportunities and a plethora of interactive sessions to fuel you and your team towards achieving your 2022

52

52

Pharmacy Times

JULY 26, 2022

The numbers dropped sharply in March 2020 from before the pandemic among men who have sex with men and individuals who inject drugs.

131

131

pharmaphorum

JULY 26, 2022

Regulators in the US and Europe have started to review Novartis’ biosimilar version of Biogen’s big-selling multiple sclerosis therapy Tysabri, which could reach the market next year. If approved, the Tysabri (natalizumab) biosimilar – originally developed by Polpharma Biologics – will be sold by Novartis’ Sandoz unit for all of the originator drug’s indications in the two markets, which span relapsing-remitting MS (RRMS), active secondary progressive MS in adults, and Cr

FDA 52

FDA 52